Concurrent therapy with approved or investigational anticancer therapeutics.
No concurrent therapy with approved or investigational anticancer therapeutics
Concurrent use of other anticancer approved or investigational agents is not allowed.
Concurrent therapy with approved or investigational anticancer therapy
Immunotherapy or chemotherapy with approved or investigational anticancer therapeutics within  weeks of first dose
Concurrent therapy with approved or investigational anticancer therapeutic other than steroids
Concurrent use of other anticancer approved or investigational agents is not allowed.
SUB-PROTOCOL AIM A: Concurrent use of any other approved or investigational anticancer agents which would be considered as a treatment for the primary neoplasm
Concurrent use of any other approved or investigational anticancer agents, including hormonal agents
Concurrent therapy with approved or investigational anticancer therapeutic
Concurrent therapy with approved or investigational anticancer therapeutic
Concurrent therapy with approved or investigational anticancer therapeutic other than steroids
Concurrent therapy with approved or investigational anticancer therapeutic other than steroids
Immunotherapy or chemotherapy with approved or investigational anticancer therapeutics within  days of first dose
Chemotherapy with approved or investigational anticancer therapeutics within  days prior to randomization.
Concurrent therapy with approved or investigational anticancer therapeutic other than steroids
Concurrent therapy with approved or investigational anticancer therapeutics
